PDL
DGX icon

Portfolio Design Labs’s Quest Diagnostics DGX Stock Holding History

Portfolio Design Labs’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
1,226
+10
+0.8% +$1.96K 0.04% 195
2026
Q1 		$238K Buy
+1,216
New +$236K 0.04% 197
2025
Q3 		– Sell
-10,506
Closed -$1.89M – 204
2025
Q2 		$1.89M Buy
10,506
+318
+3% +$55.2K 0.37% 67
2025
Q1 		$1.72M Buy
+10,188
New +$1.67M 0.36% 78

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Portfolio Design Labs's DGX Position: Q2 2026 in Review

Portfolio Design Labs increased its Quest Diagnostics (DGX) stake by 0.82% in Q2 2026, buying an estimated $1.96K and bringing the position to 1,226 shares worth $260K. The position accounts for 0.04% of the portfolio, ranked #195.

Portfolio Design Labs first reported a position in DGX in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.89M in Q2 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Portfolio Design Labs held 1,226 shares of Quest Diagnostics worth $260K as of Q2 2026.
  • Portfolio Design Labs bought 10 Quest Diagnostics shares in Q2 2026, an estimated $1.96K.
  • Quest Diagnostics made up 0.04% of Portfolio Design Labs's portfolio in Q2 2026, its #195 holding.
  • Portfolio Design Labs first reported a position in Quest Diagnostics in Q1 2025 and has held it in 4 quarters since.
  • Portfolio Design Labs's Quest Diagnostics position peaked at $1.89M in Q2 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.